Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells.

导出 OA

翻译打印收藏纠错

作者： Song,Gao ^[1] ; Yan,Pan ^[1] ; Libin,Song ^[1] ; Lei,Dong ^[2] ; Lao I,Weng ^[2] ; Peng,Wang ^[1] ; Yongqiang,Hua ^[1] ; Zhen,Chen ^[1] ; Luming,Liu ^[1]

作者单位： Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. ^[1] Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China. ^[2]

DOI 10.1155/2016/7028289

PMID 27829864

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Evidence-based complementary and alternative medicine

2016年2016卷

7028289页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells.

Evidence-based complementary and alternative medicine

相似文献

Evidence-based complementary and alternative medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells.

Evidence-based complementary and alternative medicine

相似文献

Evidence-based complementary and alternative medicine

相关期刊

检索历史清除